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Slllnmary 
We recently reported the purification of a lymphocyte granule protein called "fragmentin," which 
was identified as a serine protease with the ability to induce oligonucleosomal DNA fragmentation 
and apoptosis (Shi, L., K. P. Kraut, R. Aebersold, and A. H. Greenberg.  1992. J. Exp. Med. 
175:553). We have now purified two additional proteases with fragmentin activity from lymphocyte 
granules. The three proteases are of two types; one has the unusual ability to cleave a tripeptide 
thiobenzyl ester substrate after aspartic acid, similar to murine cytotoxic cell protease I/granzyme 
B, while two are tryptase-like, preferentially hydrolyzing after arginine, and bear some homology 
to human T cell granule tryptases, granzyme 3, and Hanukah factor/granzyme A. Using tripeptide 
chloromethyl ketones,  the pattern of inhibition of DNA fragmentation corresponded to the 
inhibition of peptide hydrolysis. The Asp-ase fragmentin was blocked by aspartic acid-containing 
tripeptide chloromethyl ketones,  while the tryptase  fragmentins were inhibited by arginine- 
containing chloromethyl ketones. The two tryptase fragmentins were slow acting and were partly 
suppressed by blocking proteins synthesis with cydoheximide in the YAC-1 target cell. In contrast, 
the Asp-ase fragmentin was fast acting and produced DNA damage in the absence of protein 
synthesis. Using a panel of unrelated target cells of lymphoma, thymoma, and melanoma origin, 
distinct patterns of sensitivity to the three fragmentins were observed. Thus, these three granule 
proteases make up a family of fragmentins that activate DNA fragmentation and apoptosis by 
acting on unique substrates in different  target cells. 
T 
he molecular mediators of lymphocyte-induced  cytolysis 
are thought to reside within the cytoplasmic granules 
of CTL and NK cells (1--4). The delivery of these molecules 
to the plasma membrane of the target cells occurs by exocy- 
tosis (5) and has been detected by the release of granule con- 
stituents into the intercellular  space between the killer cell 
and target (6, 7). The destruction of the target cells appears 
to be of two distinct forms:  the dissolution of the plasma 
membrane and apoptosis, including the characteristic cleavage 
of DNA into oligonucleosomal fragments (for review see ref- 
erence 8). One of the constituents of the cytoplasmic granules 
is the pore-forming protein called either perforin in the T 
cell (3) or cytolysin in the NK cell (2), which is capable of 
disrupting the target cell membrane but is unable to produce 
the DNA damage identified after CTL and NK cell-medi- 
ated killing (1, 8, 9). In addition to perforin/cytolysin,  a sub- 
family of serine proteases has been identified in lymphocytes 
(10, 11) that is stored in cytoplasmic granules (12, 13). Exo- 
cytosis of granules results in the release of serine proteases 
into the extracellular environment (14). The lymphocyte serine 
proteases, sometimes called "granzymes" have been identified 
in human (15-17), murine (10, 18, 19), and rat (20) homo- 
logues, with as many as seven distinct genes now identified 
in mice and three in humans. The specificity of only two 
gene products has been determined. Granzyme A/Hanukah 
factor (HF)  1 was originally discovered by its ability to cleave 
the Not-CBZ-t-lysine  thiobenzyl ester (BLT) substrate (14), 
and was subsequently identified as a tryptase, while murine 
cytotoxic protease I (CCPI)/granzyme B was found to be 
an asp-ase (21-23),  Other protease activities have been de- 
tected in the rat NK granules, although the proteins medi- 
ating the hydrolysis have not been identified  (24). 
In an earlier publication, we reported the purification  of 
a granule protein called fragmentin, which, in the presence 
~Abbreviations used in this paper: BLT, Ntx-CBZ-t-lysine thiobenzyl ester; 
CCPI, routine cytotoxic cell protease  I; HF, Hanukah factor. 
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fragmentation and apoptosis in intact target cells (1). Amino 
acid sequencing of internal peptides indicated that the pro- 
tein was similar to the rat natural killer protease 1 (RNKP-1), 
which is likely the species homologue of murine CCPI/gran- 
zyme B (1).  This observation suggested that granule serine 
proteases may play a direct role in mediating cell-mediated 
cytotoxicity and  apoptosis.  In  the present  study,  we have 
identified two additional lymphocyte granule proteases that 
can induce target cells to undergo DNA fragmentation with 
different efficiencies and  through  unique  substrate interac- 
tions.  Of the three proteases, one is fast acting and induces 
DNA damage through its asp-ase activity, while the other 
two are slow-acting tryptases. The asp-ase was the protease 
showing homology to RNKP-1 and CCPI/granzyme B (1), 
while one tryptase reported in this paper resembled HF/gran- 
zyme A  (15,  16,  19) and the second tryptase was homolo- 
gous  to human  granzyme 3  (17). 
Materials and Methods 
Cells.  The RNK-16 tumorcell line used as the source of  granules 
has  been  described previously (1). It  was  serially  passaged  in- 
traperitoneally in pristine-primed F344 rats (Fisher Scientific Co., 
Pittsburgh, PA). YAC-1 T cell lymphoma and A1.1 thymoma target 
cells were maintained in RPMI 1640 and B16 melanoma in o~-MEM 
supplemented with 10% FCS, penicillin-streptomycin, and 2 mM 
t-glutamine. 
Purification of  Fragmentin Proteins.  The purifications of the 31- 
32-kD fragmentin 2 and the 27-kD BLT-esterase, now called frag- 
mentin 3, have been described in detail (1). Fragmentin I was purified 
from the same granule preparation. The mono-Q fractions were 
screened for both 12sI-UdR release activity in a 2-h cytotoxicity 
assay in the presence of a constant amount of cytolysin, and for 
BLT-esterase activity. Fractions containing cytotoxic activity were 
pooled and used for purification of fragmentins 2 and 3. The re- 
maining fractions containing BLT-esterase activity were pooled and 
concentrated with  a Centricon 30 microconcentrator (Amicon 
Corp., Danvers,  MA) to a final volume of 1 ml, then diluted to 
5 ml in 20 mM Tris-HC1,  pH 7.4, 0.1  mM EGTA, and 0.02% 
NaN3 (TEB) to give a final NaC1 concentration of 0.1 M. This 
was applied to a 1-ml Heparin Hi-trap (Pharmacia  LKB Biotech- 
nology, Piscataway, NJ) connected to the FPLC system. Fractions 
were eluted with a linear gradient of 0-1 M NaC1 in TBE for 100 
min, at a flow rate of 0.2 ml/min,  and 1-ml fractions were col- 
lected and screened  in the BLT-esterase assay. The fractions con- 
taining BLT-esterase activity were pooled, concentrated, and buffer 
changed to 10 mM bis-Tris, pH 6.0, containing 50 mM NaC1 (BT), 
using a Centricon 30 microconcentrator (Amicon Corp.). This pool 
in a 12-ml volume was applied to mono-S beads (FIR 5/5) for 12 
min, and the column was washed with BT for 8 min. Fractions 
were eluted with two gradients, 5 min of 0-0.5 M NaC1 and 20 
rain of 0.5-1 M NaC1 in BT. The flow rate was  1 ml/min, and 
1-ml fractions were collected and screened with the BLT-esterase 
assay. The purity of each fraction from the peak of BLT-esterase 
was assessed by SDS-PAGE under reducing and nonreducing con- 
ditions. 
Purification  of  Cytolysin.  The method for purification ofcytolysin 
has been described previously (1). 
Assay Of  DNA Damage.  Tumor cells were labeled as described 
by Shi et al. (1). Briefly, 5-10 #Ci 12sI-UdR was added to 2-5  x 
106 YAC-1 cells in 0.5 ml supplemented RPMI  1640.  The cells 
were incubated at 37~  in a 5% CO2 atmosphere for 90 rain, 
washed twice in HBSS, incubated an additional 30 min, then w~shed 
once and resuspended at 1.25  x  10  s cell/ml in I-IBSS containing 
2 mM CaClz, 10 mM Hepes, 4 mg/ml BSA, pH 7.2 (HH-BSA). 
Tumor cells (104 cells in 80/~1) in HH-BSA and 80 #l of test pro- 
tein in HE (10 mM Hepes, pH 7.2 containing 140 mM NaC1 and 
1  mM  EGTA) were incubated  in  96-well  V-bottomed or flat- 
bottomed microtiter plates at 370C for 2 h or as indicated. Then, 
40 #1 of 1% Triton X-100 in 50 mM EGTA and 50 mM Tris-HC1, 
pH 7.2, was added to the reaction well. The contents were mixed, 
and the plates centrifuged at 800 g for 5 min. Half of the superna- 
tant was harvested from each well and soluble  12sI-UdR was de- 
termined in a Compugamma universal gamma counter (1282; Wallac 
LKB). The specific isotope release was determined as described (1). 
In assays using protease inhibitors, inhibitors were dissolved in 
DMSO at a concentration of 200 mM and stored at 4~  Inhibi- 
tors were diluted in HE medium and incubated with a constant 
amount of fragmentin or cytolysin at room temperature for 15 min 
in the assay wells, then target cells were added. The tripeptide chlo- 
romethyl ketones were synthesized as described previously (25). 
In assays using cycloheximide (Sigma Chemical Co., St. Louis, 
MO), the drug was freshly prepared in HH-BSA at a concentra- 
tion of 50/~g/rnl and incubated with x~I-UdR-labeled YAC-1 cells 
for 2 h at 37~  before the cytotoxicity assay. 
SDS-PAGE.  Proteins were run on 6-cm 12% gels according 
to Laemmli (26).  An additional 1 cm of 4% gel was added over 
the running gel to resolve high molecular mass bands.  Gels were 
developed with a commercial silver stain kit (Bio-Rad Laborato- 
ties,  Richmond,  CA). 
NHrterminal  Amino  Acid Sequencing of Fragmentin 3.  For 
NH2-terminal sequence analysis, proteins were separated by PAGE, 
electroblotted onto Immobilone P membrane (Milllpore Continental 
Water Systems,  Bedford, MA),  and detected by coomassie  blue 
staining as described (27). Selected bands were cut out and sequenced 
in a protein sequencer (477A; Applied Biosystems, Inc., Foster City, 
CA) using standard protocols. Resulting phenylthioliydantoin de- 
rivatives  were separated  in a HPLC system (120A;  Applied Bi- 
osystems,  Inc.) and identified by visual inspection. 
Substrate Kinetics.  The enzymatic hydrolysis ofpeptide thioester 
substrates by fragmentins 2 (batches 1 and 2) and 3 were measured 
in  0.1  M  Hepes,  0.5  M  NaC1,  pH  7.5,  buffer containing 8% 
Me2SO and at 25~  in the presence of 4,4'-dithiodipyridine  (PDS) 
(27), and hydrolysis rates of thioester substrates  by fragmentins 1 
and 2 (batch 3) were measured in 0.1 M Hepes, 0.5 M NaC1,  1 
mM EDTA, pH 7.5, buffer containing 13% MezSO and at 21~ 
in the presence of 5,5'-dithio-bis(2-nitrobenzoic acid) (DNTB) (28, 
29). Stock solution of substrate was prepared in Me2SO and stored 
at  -20~  For fragmentins 2 and 3, the initial rates were mea- 
sured at 324 nm (e324 =  19800 M-:/cm-~) using a spectrophoto- 
meter (Beckman Instruments, Inc., Palo Alto, CA) when 5 or 10 #I 
of an enzyme stock solution was added to a cuvette containing 
2.0 ml of buffer, 0.15 ml of 5 mM PDS,  and 25 #1 of substrate. 
The same volumes of substrate and PDS were added to the refer- 
ence cell to compensate for the background hydrolysis rate of the 
substrates.  For fragmentins 1 and 2, the initial rates were measured 
at 405 nm (e40s =  14,000 M-1/cm -t) using a microplate reader 
(Termomax) when 2 #1 of an enzyme stock solution was added 
to a well containing 0.2 ml of buffer, 0.02 ml of 5 mM DTNB, 
and 10/~1 of substrate.  The same volumes of substrate and DTNB 
were added to the blank well to compensate for the background 
hydrolysis rate of the substrates. Initial rates were measured in dupli- 
cate for each substrate concentration and were averaged in each case. 
1522  Three Cytotoxic Lymphocyte Granule Proteases That Induce Apoptosis Inhibition  Kinetics:  Incubation  Method.  The inactivation reaction 
was  initiated  at  21~  by  adding  a  10-#1  aliquot  of inhibitor  in 
Me2SO;  concentration  was 8%.  Aliquots were removed at various 
time intervals,  diluted  into  substrate  solution  (90-fold  dilution), 
and the residual activity was measured spectrophotometrically with 
a microplate reader. Fragmentins  I and 3 were assayed with Z-Arg- 
SBzl,  and  fragmentin  2  was  assayed with  Boc-Ala-Ala-Asp-SBzl. 
First-order  inactivation  rate  constants  (kob,) were  obtained  from 
plots in In substrate hydrolysis rate at  time t/substrate  hydrolysis 
rate at time 0  vs. time. Several inhibitors did not show any inhibi- 
tion toward fragmentins after a 10-rain incubation of enzyme with 
inhibitor. 
Results 
Identification of Three Granule Proteases (Fragmentins) with 
DNA Fragmenting Activity.  The 31-32-kD fragmentin de- 
scribed in our earlier publication,  along with a 27-kD BLT- 
esterase, were  prepared by FPLC chromatography  (1) and 
identified as single bands on SDS-PAGE under reducing and 
nonreducing conditions  (Fig. 1, A, B, D, and E). While the 
27-kD BLT-esterase  was highly abundant, we noted a second 
smaller BLT-esterase peak on Mono-Q chromatography (Fig. 
2 A), which had been excluded from  the first purification 
protocol, and subjected this peak to sequential heparin agarose 
(Fig.  2 B) and Mono-S (Fig.  2 C) columns,  as described in 
Materials and Methods. The Mono-S protein peak containing 
this second BLT-esterase ran as a single band at '~47 kD under 
nonreducing  conditions  on SDS-PAGE and at 30 kD after 
reduction (Fig. 1, C and F). The molecular mass was similar 
to human HF/granzyme  A  (15, 17),  which is also a BLT- 
esterase that  runs as  a  43-kD  homodimer  and  a  30-kD 
monomer under nonreducing and reducing conditions, respec- 
tively. This distinguishes  it from the more abundant BLT- 
esterase, which ran at 27 kD under nonreducing conditions 
(Fig.  1 B). 
Figure  1.  SDS-PAGE of purified lymphocyte granule proteases. FPLC- 
purified  proteases  were loaded  on a 12%  gel run according  to Laemmli 
(26) under reducing  (lanes A-C) and nonreducing conditions (lanes D-F), 
then silver stained.  Lanes A  and D contain 0.6/xg of the 31-32-kD frag- 
mentin protein (1), lanes B and E contain 0.6/~g of the major BLT-esterase 
that copurified  with fragmentin (1),  and lanes C  and F  contain 0.16/~g 
of the second minor BLT-esterase purified from the same granules  as de- 
scribed in Materials  and Methods and shown in Fig.  2. Molecular  mass 
markers are shown  to the left of the stained  gels. 
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Figure  2.  Purification  of an KNK granule  BLT-esterase. After an ini- 
tial  step  of phenyl  superose  chromatography  to  remove cytolysin  (see 
Materials  and Methods),  fractions  containing BLT-esterase activity were 
applied to a Mono-Q column (,4). Two BLT-esterase  peaks were identified. 
The fractions containing  the minor peak (arrow)  were pooled, concentrated, 
and applied to a heparin agarose column (B). Fractions containing the peak 
of BLT-esterase were pooled, concentrated,  and buffer changed  to 10 mM 
bis-Tris, pH 6.0, containing 50 mM NaC1,  and applied to Mono-S beads 
(C). Fractions were eluted,  and the BLT-esterase peak was concentrated, 
desalted,  and  run on SDS-PAGE  (see Fig.  1,  C  and F). 
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Figure 3.  DNA fragmentation of YAC-1 cells by purified granule pro- 
teases. Fragmentins 1 (A), 2 (e), and 3 (I) were examined in a 2-h (.4) 
and 20-h (B) cytotoxicity assay. None of the proteases were active in the 
absence of cytolysin (open symbols). 
All three proteins were able to induce DNA fragmenta- 
tion of YAC-1 cells (Fig.  3). However,  after a 2-h incuba- 
tion, DNA damage of YAC-1 cells was only observed with 
the 31-kD fragmentin in the presence of a constant amount 
of cytolysin (Fig.  3 A). By 20 h, both the 47- and 27-kD 
BLT-esterases  induced significant DNA damage, but only when 
cytolysin was present and at a specific activity that was lower 
than the 31-kD fragmentin (Fig. 3 B). Thus, two additional 
1  2  3  4  5  6  7  8  9  10  11 
FRAGMENTIN  3  Xxx  -  lie  -  Gly  -  Gly  -  Xxx  -  Glu  -  Val  -  Gin  -  Pro  -  His  -  Ser 
HuGRANZYME3  lie  -  *  -  *  -  *  -Lys-  *  -  *  -Ser-  *  -  *  -  * 
HuGRANZYMEA  lie-  *  -  *  -  *  -Ash-  *  -  *  -Thr-  *  -  *  -  * 
MuGRANZYMEA  lie  -  *  -  *  -  ,  -Asp-Thr-  *  -Val-  *  -  *  -  * 
12  13  14  15  16  17  18  19  20  21  22 
FRAGMENTIN  3  Xxx  -  Pro  -  Phe  -  Met  -  Ate  -Ala  -  lle  -  Gin  -  Tyr  -  Xxx  -  Gly 
HuGRANZYME3  Arg-  *  -  *  -  *  -  * 
HuGRANZYMEA  Arg-  *  -Tyr  -  *  -Val-  Leu-Leu-Ser-Leu-Asp-Arg 
MuGRANZYMEA  Arg-  *  -  Tyr  -  *  -  *  -  Leu-Leu-Lys-Leu-Leu-  Ser 
Figure 4.  NH2-terminal  amino acid  sequence of the  27-kD  BLT- 
esterase fragmentin 3. The sequence is compared to the other known BLT- 
esterases, gtanzyme 3  (17), and human and murine Hanukah factor/ 
granzyme A (15, 16, 19). 
fragmentins  with  considerably  slower  kinetics  and lower 
specific activity  are present in the IkNK granule. We have 
named these three proteins fragmentin 1 (47 kD, unreduced 
apparent molecular mass), fragmentin 2 (31 kD), and frag- 
mentin 3 (27  kD) in our further discussions. 
We sequenced the NH2-terminal amino acids of the 27-kD 
BLT-esterase fragmentin  3 to further identify this protein. 
The sequence contained the conserved regions of the gran- 
zyme family and was most homologous to human granzyme 
3 (17), which is one of only two known granule BLT-esterases 
(Fig. 4). It differed significantly from the other BLT-esterase, 
human and murine HF/granzyme A (Fig. 4), particularly in 
Table  1.  Enzymatic Hydrolysis Rate of Peptide Thiobenzyl Esters by Fragmentins 
Hydrolysis rate 
Substrates  [S]  Fragmentin 1"  Fragmentin 2,  Fragmentin 3t 
/~M  nM/s 
Boc-Ala-Ala-Asp-SBzl  115  0.6  51  0 
211  27.2* 
Boc-Ala-Ala-Met-SBzl  116  0  40  0 
144  4.7* 
Boc-Ala-Ala-Ser-SBzl  115  0 
133  0  8.4 
Boc-Ala-Ala-Asn-SBzl  144  4.2 
Boc-Ala-Ala-Glu-SBzl  0 
Suc-Phe-Leu-Phe-SBzl  115  0.1  0.8  0 
Z-Arg-SBzl  106  135 
115  8.2 
131  3.0*  11.7 
* Hydrolysis rates were measured in 0.1 M Hepes, 0.5 M NaCI, 1 mM EDTA, pH 7.5, and 13%  Me2SO at 21~  An aliquot of 2 #1 of the 
enzyme was added to the assay mixture containing 0.2 ml of buffer,  0.02 ml of 5 mM DTNB, and 10 #1 of substrate.  Enzyme concentrations 
were:  fragmentin 1,  1.7 nM; ffagmentin 2,  8.4 nM (batch 2). 
* Hydrolysis rates were measured in 0.1 M Hepes, 0.5 M NaCI, pH 7.5, and 8% Me2SO at 25~  An aliquot of 5 or 10 #1 of the enzyme was 
added to the assay mixture containing 2 ml of buffer, 0.15 ml of 5 mM PDS,  and 25 #1 of substrate,  Enzyme concentrations  were:  fragmentin 
2,  7.3 nM (batch  1); fragmentin 3,  6.2 nM. 
1524  Three Cytotoxic  Lymphocyte Granule Proteases That Induce Apoptosis Table  2.  Inhibition of DNA Fragmentation (IDso) by Chlorometh),l Ketones 
Chloromethyl ketones* 
Molecular mass 
(nonreduced)  Asp  Nle  Phe  Arg  Trp 
kD  ,uM 
Fragmentin 1  47  >250  NT*  NT  0.25  NT 
Fragmentin 2  31  0.3  50  22  155  12 
Fragmentin 3  27  >250  >250  125  0.18  15 
* Amino acid refers to the third position in a tripeptide chloromethyl ketone. Asp, Boc-AIa-Ala-Asp-CH2C1;  Nle, Boc-Ala-AIa-Nle-CH2CI;  Phe, 
Boc-Gly-Leu-Phe-CH2C1; Arg, D-Phe-Pro-Arg-CH2C1; Trp, Z-Trp-CH2C1. 
NT,  not tested. 
position 14, which is a conserved tyrosine, and positions  17, 
18, and 20, which are conserved leucines. 
Substrate and Inhibitor Studies of the Fragmentins.  To iden- 
tify the specificity of peptide hydrolysis by ffagmentins 1, 
2, and 3, we utilized thiobenzyl ester substrates  (Table 1). 
Fragmentin 1 had high enzymatic activity toward Z-Arg-SBzl, 
but had very low or no activity toward other substrates. Frag- 
mentin 2 had primarily Boc-Ala-Ala-Asp-SBzl  esterase activity, 
but contained Boc-Ala-Ala-Met-SBzl  activity in some enzyme 
batches. Fragmentin 2 also slowly hydrolyzed Ser-, Ash-, Phe-, 
and Arg-containing substrates. Fragmentin 3, like fragmentin 
1, was active toward Z-Arg-SBzl, but had no activity against 
other thioester substrates. The asp-ase activity of fragmentin 
2 was not enhanced by fragmentin 3. Fragmentin 2 (23 nM) 
was incubated with fragmentin 3 (52 nM) for 0.5,  10, and 
30 rain;  the asp-ase activity was not increased when com- 
pared to fragmentin 2 in buffer for the same period of time. 
Similarly, the tryptase activity of fragmentin 3 was not en- 
hanced by fragmentin 2. Fragmentin 3 (52 nM) was incubated 
with fragmentin 2 (23 nM) for 0.5,  10, and 30 rain, and 
the tryptase activity was not greater than the sum of frag- 
mentins 3 and 2 alone in buffer for the same period of time. 
To identify the substrates that were important for DNA 
fragmentation, a series of tripeptide chloromethyl ketones 
were tested as inhibitors. These compounds are able to form 
a tetrahedral complex with protease-active site residues and 
permanently inactivate serine proteases (30). By comparing 
chloromethyl ketones  with various  amino acid sequences, 
unique inhibitors were identified that have allowed us to dis- 
tinguish the DNA fragmentation induced by these three frag- 
mentin proteins (Table 2). The fast-acting fragmentin 2 was 
completely blocked by Boc-AIa-AIa-Asp-CH2C1 (IDs0, 0.3 
#M) but was poorly inhibited by the other chloromethyl 
ketones  (IDs0, 12-155 /zM). In contrast,  the slow-acting 
fragmentins 1 and 3 were both highly inhibited by D-Phe- 
Pro-Arg-CH2C1 (IDs0, >250 #M).  Fragmentin 3 was not 
inhibited by Nle- or Phe-containing chloromethyl ketones, 
but was moderately inhibited by Z-Trp-CH2C1. The inhibi- 
tion of enzymatic activities of fragmentins by peptide chlo- 
romethyl ketones was also examined (Table 3). Fragmentins 
1 and 3, which have trypsin-like activity, were only inhibited 
by a potent thrombin inhibitor, o-Phe-Pro-Arg-CH2C1, but 
not inhibited by the other four chloromethyl ketones. Frag- 
mentin 2, which contained asp-ase and met-ase activities, was 
inhibited  by  Boc-Ala-Ala-Asp-CHzCI  and  Z-Trp-CH2C1. 
Generally, the inhibition of enzymatic activities of these frag- 
Table  3.  Inhibition of Fragmentins by Peptide Chloromethfl Ketones 
Kob,/[I] 
Inhibitor  [I]  Fragmentin 1  Fragmentin 2  Fragmentin 3 
#M  M/s 
Boc-Ala-Ala-Asp-CH2C1  380--446  NI*  3.0  NI 
Boc-Ala-Ala-NIe-CH2CI  405-439  NI  NI  NI 
Boc-Gly-Leu-Phe-CHzC1  408-442  NI  NI  NI 
D-Phe-Pro-Arg-CHzC1  400-430  9.0  NI  77 
Z-Trp-CH2C1  385-410  NI  36  NI 
Inhibition was measured in 0.1 M Hepes, 0.5 M NaC1, 1 mM EDTA, pH 7.5, and 8% Me2SO at 21~  Z-Arg-SBzl (120/zM),  Boc-Ala-Ala- 
Asp-SBzl (210/zM), and Z-Arg-SBzl (300 #M) were used as the substrates for fragmentins 1, 2, and 3,  respectively. 
" No inhibition  after 10 min of incubation of enzyme and inhibitor. 
1525  Shi et al. mentins by peptide chloromethyl ketones was consistent with 
the inhibition results  of the DNA fragmentation. 
Requirement  for Protein Synthesis  for DNA Damage by Frag- 
mentins.  The slow kinetics of DNA damage produced by 
the tryptase fragmentins 1 and 3 contrast sharply with the 
rapid action of the asp-ase fragmentin 2. Induction of DNA 
fragmentation and apoptosis by many agents is slow and re- 
quires protein synthesis (31, 32). We examined the relative 
DNA damage produced by the fragmentins, with or without 
pretreatment of YAC-1 cells with 50 #g/ml cydoheximide. 
The DNA damage produced by fragmentin 2 is unaffected 
by cydoheximide in either a rapid 2-h assay or after a longer 
14-h incubation (Fig. 5). In contrast, fragmentin 1 and 3 ac- 
tivity in 14-18-h assays was reduced by 30-40% after cydo- 
heximide treatment, indicating that at least part of their ac- 
tivity was dependent upon protein synthesis. 
Differential Susceptibility of Target Cells to Granule Frag- 
mentins.  The existence of at least three granule fragmentins 
with unique substrate specificities suggested that they may 
induce DNA fragmentation at varying rates in different target 
cells. We have examined several target cells, including the 
YAC-1 lymphoma, A1.1 thymoma, and B16 mdanoma, and 
found unique patterns of DNA fragmentation in each call 
line when assessed after a 20-h assay (Fig. 6). YAC-1 tumor 
cells are preferentially  damaged by fragmentin 2, while the 
A1.1 thymoma is barely affected by this protease. In contrast, 
fragmentin 1 efficiently induces DNA damage in the A1.1 
thymoma, while being the least effective against the B16 mela- 
noma. Fragmentin 3 is active against all of the tumor cell lines. 
Discussion 
In an earlier  publication we described a rat lymphocyte 
granule protease that rapidly induced DNA fragmentation 
and apoptosis in YAC-1 cells in the presence  of perforin/ 
cytolysin (1). This molecule was homologous to the rat NK 
protease 1, and its activity could be blocked by the general 
serine protease inhibitor, 3,4-dichloroisocoumarin. In this 
manuscript, we have identified the protease as an asp-ase and 
describe two additional granule serine proteases with frag- 
J  80- 
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~  20- 
A  Fragmentln I 
80- 
B  ~min  2 
Cytolysin ng/ml  120  120  120  120  120  120  120  120  120  120 
C  Fragmentin 3 
1000 5O0  25O  125  0 
120  120  120  120  120 
Figure  5.  Requirement for protein synthesis to induce DNA damage 
by the fragmentins. DNA damage induced by fragmentins after treatment 
of YAC-1 cells with 50/zg/ml of cycloheximide  (CHX) (filled symbols) 
or control medium (open symbols) in a 2-h (circles) or a 14-18-h (triangles) 
cytotoxicity assay. Inhibition of [3H]methionine  incorporation was 92% 
at 50/~g/ml CHX. In two experiments, the ID40 for fragmentin 1 was 
37%  and 32%,  and fragmentin 3 was 44%  and 31%,  respectively. 
mentin activity that are tryptases. These proteases differ from 
the asp-ase fragmentin in their substrate specificity, inhibi- 
tory activity by chloromethyl ketones, kinetics of action, 
requirement for protein synthesis to mediate DNA fragmen- 
tation, and target cell preference. A summary of these char- 
acteristics is given in Table 4. 
One of the tryptase fragmentins appeared to be a dimer 
that ran at 47 kD under nonreducing conditions, and at 30 
kD as monomers under reducing conditions. This is similar 
to the molecular mass described for human granzyme A (15), 
but  differs  from the  60-kD  dimeric BLT-esterase affinity 
purified from the RNK leukemia cell line, which was identified 
as granzyme A  (4). The reason for this discrepancy is not 
immediately apparent. The second BLT-esterase  we identified 
was 27 kD under nonreducing conditions, and had NH2- 
terminal sequence homology to human granzyme 3 (17), the 
only other BLT-esterase that has been identified in lympho- 
cyte granules.  The 27-kD BLT-esterase was more abundant 
than the 47-kD granzyme A-like BLT-esterase  in the RNK-16 
granules.  This is not the case for routine and human CTL 
granules, where granzyme A is the major BLT esterase (15, 
17). It is not clear if this is a difference between NK cell and 
CTL lines, a species difference, or a peculiarity of the IkNK- 
16 tumor. However, in the studies of substrate specificity and 
inhibition of qualitative  activity of these proteins, we find 
little functional difference between them. The three proteases, 
therefore, fall into two groups based on substrate specificities. 
Fragmentins 1 and 3 are tryptases and preferential hydrolyze 
the Z-Lys-SBzl and Z-Arg-SBzl substrates,  similar to gran- 
zyme A (21-23), and ftagmentin 2 is an asp-ase, cleaving most 
efficiently Boc-Ala-Ala-Asp-SBzl and, to a lesser extent, the 
Boc-Ala-Ala-Met-SBzl substrate. Granzyme B also has a prefer- 
ence for the Ala-Ala-Asp-SBzl substrate with some activity 
against Ala-Ala-AA-SBzl where AA is either Met, Asn, or 
Set (21). However, the possibility that fragmentin 2 is con- 
taminated with a met-ase also exists due to the observation 
that met-ase activity varies between batches of purified en- 
zyme (Table 1). The inhibitory activities  of fragrnentins by 
chloromethyl ketones using thioester substrates are generally 
consistent with the inhibition results of their DNA fragmen- 
tation.  D-Pbe-Pro-Arg-CH2C1  was the only chloromethyl 
ketone that inhibited fragrnentins 1 and 3, although the in- 
YAC-1  LYMPHOMA  A1.1  THYMOMA  B16  MELANOMA 
i  I  1  i  i  i  i  i  i  i  i  f  ~  i  i 
250  125  63  32  16  1000  500  250  125  63  1000  500  2  0  ~;25  63 
Fragmentin (ng/ml)  Fragmentln (ng/ml)  Fragrnentln (ng/ml) 
Figure 6.  Differential susceptibility of target cells to fragmentins. Using 
a 20-h assay, fragmentins 1 ($), 2 (ll), and 3 (&) induced DNA damage 
in YAC-1 lymphoma, A1.1 thymoma, and B16 mdanoma with varying 
efficiency. 
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hibition rates were slow. Surprisingly,  Z-Trp-CH2CI was a 
more  potent  inhibitor  than  Boc-Ala-AIa-Asp-CH2CI for 
fragmentin 2 on the inhibition of its enzymatic hydrolysis 
of Boc-Ala-Ala-Asp-SBzl. This contrasts with the preferen- 
tial inhibition of DNA damage by Boc-Ala-Ala-Asp-CH2C1 
(Table 2). The reasons for this are unclear, but might reflect 
substrate availability in vivo, where the asp-use activity would 
be more important for inducing DNA fragmentation. 
The asp-use and tryptase  fragmentins differ considerably 
in their kinetics and specific activity. The asp-use fragmentin 
2 was very fast acting, producing DNA damage in <2 h (1), 
while fragmentins 1 and 3 required longer assays and much 
higher protein concentrations to be detected (1) (Fig. 3). The 
reasons for this difference may be partly explained by the ob- 
servation that at least some of the fragmentin 1 and 3 ac- 
tivity required new protein synthesis. This is similar to apop- 
toffs induced by agents such as anti-CD3 antibody (32) and 
glucocorticoids  (31), where DNA damage can be abrogated 
by inhibitors of protein synthesis. Thus, both protein syn- 
thesis-dependent and -independent pathways of killing can 
be mediated by the same fragmentin protease. An explana- 
tion for this observation  will need a better understanding 
of the molecular mechanisms of apoptosis. 
One of the important questions that needs to be addressed 
is why more than one fragmentin exists in the lymphocyte 
granule. If these proteases mediate the apoptosis induced by 
NK cells and CTL, then a diversity of effector molecules must 
give some advantage in killing. Serine proteases have been 
shown to activate enzymes of the dotting cascade (33, 34), 
which might suggest that activating interactions may occur 
between fragmentins. However, we have been unable to dem- 
onstrate fragmentin 3 enhancement of fragmentin 2 hydrol- 
ysis of Boc-Ala-Ala-Asp-SBzl, or fragmentin 2 enhancement 
of fragmentin 3 hydrolysis of Z-Arg-SBzl. Another possibility 
is that the proteases cleave  distinct proteins and each is capable 
of activating the apoptotic pathway independently, resulting 
in synergistic amplification of DNA damage in a target cell. 
This hypothesis is supported by our observation  that frag- 
mentin 3 synergistically amplifies DNA damage of YAC-1 
cells by fragmentin 2 (1). Finally, since each fragmentin is 
apparently capable of acting as an effector molecule, then per- 
haps  their ability  to cleave different  substrates  will allow 
preferential activation of the apoptotic pathway in different 
target cells. This possibility  was confirmed by identifying 
unique patterns  of DNA damage induced by the three frag- 
mentins in different target cells (Fig. 6). The differential ability 
to induce target cell damage by the fragmentins has potential 
implications for the interpretation of the specificity of killing 
by granulated cytotoxic lymphocytes. That is, susceptibility 
to killing may be determined not only by membrane receptor 
interactions, but by the susceptibility of the target cell to and 
the abundance  of a given fragmentin in the cytotoxic cell 
granule. 
In conclusion, we have identified a family of lymphocyte 
granule protease fragmentins that induce apoptosis through 
unique substrate and target cell interactions, and suggest that 
they are important mediators  of lymphocyte cytotoxicity. 
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